Immatics N.V. Ordinary Shares - gráfico, preços e notícias (NASDAQ:IMTX) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Market Capitalization 15.43 M
Employee 407
Founded 2000
CEO Harpreet Singh
Website www.immatics.com
Headquarter Netherlands
FIGI N/A
Industry Biotecnologia

Notícias

Lucro da Immatics NV veio abaixo das projeções por €0,04; receita menor do que estimativas

Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates

TD Cowen inicia cobertura de ações da Immatics com recomendação de compra

Immatics anuncia quatro apresentações orais no encontro da ASCO

Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)